Peralta, Erlinda M.

HRN: 01-07-06  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/08/2026
CEFTRIAXONE 1G (VIAL)
05/08/2026
05/14/2026
IV
2g
OD
Pleural Effusion, Right Prob Sec To CAP-MR
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines